Self-medication of anxiety disorders with alcohol and drugs: Results from a nationally representative sample

Department of Psychology, University of Manitoba, Winnipeg, Manitoba, Canada.
Journal of Anxiety Disorders (Impact Factor: 2.96). 04/2008; 23(1):38-45. DOI: 10.1016/j.janxdis.2008.03.013
Source: PubMed

ABSTRACT Self-medication--the use of alcohol or drugs in an attempt to reduce anxiety--has often been invoked as an explanatory mechanism for the high co-occurrence of anxiety and substance use disorders (for reviews, see Allan, C. A. (1995). Alcohol problems and anxiety disorders-A critical review. Alcohol & Alcoholism, 30(2), 145-151; Kushner, M. G., Abrams, K., & Borchardt. (2000). The relationship between anxiety disorders and alcohol use disorders: A review of major perspectives and findings. Clinical Psychology Review, 20(2), 149-171). The current study expands upon previous self-medication research by: (1) examining prevalence and comorbidity of self-medication for anxiety disorders (panic disorder, social phobia, specific phobia, and generalized anxiety disorder); (2) using a nationally representative sample (National Epidemiologic Survey on Alcohol and Related Conditions; N=43,093) to do so; and (3) by differentiating self-medication with alcohol from self-medication with drugs. Prevalence rates ranged from 18.3% (self-medication with alcohol for generalized anxiety disorder) to 3.3% (self-medication with both alcohol and drugs for specific phobia and panic disorder without agoraphobia). Multiple logistic regression analyses determined that self-medication with alcohol was associated with increased likelihood of any mood or personality disorder diagnosis, while self-medication with both alcohol and drugs further increased these associations over and above self-medication with alcohol alone. Findings remained significant after adjusting for sociodemographic and substance use disorder variables, which suggests that independently of substance use disorders, self-medication can be viewed as a marker of severity.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Alcoholism is a chronic relapsing brain disorder. Several clinical and preclinical studies indicate that alcohol use disorders (AUD) and anxiety disorders are highly correlated and have a shared etiology, promoting each other’s development and also feeding back into each other’s maintenance. The molecular and epigenetic mechanisms in specific brain circuitry such as the central nucleus of amygdala (CeA) may be involved in the comorbidity of anxiety and alcoholism. Innate or ethanol-induced changes in signaling cascade pathways leading to adaptations at the level of cAMP responsive element–binding (CREB) protein gene-transcription factor function and associated chromatin remodeling due to histone modifications and DNA methylation in the CeA have become one of the emerging mechanisms underlying AUD and anxiety. Studies conducted in the field suggest that histone deacetylases and DNA methyltransferase inhibitors may be potential therapeutic agents to treat or prevent alcoholism with or without comorbid anxiety disorders.
    Neurobiology of Alcohol Dependence, 1st edited by A Noronha, C. Cui, R.A. Harris, J.C. Crabbe, 01/2014: chapter 22: pages 451-466; Elsevier Inc., ISBN: 978-0-12-405941-2
  • [Show abstract] [Hide abstract]
    ABSTRACT: Alcoholism is a complex psychiatric disorder that has a multifactorial etiology. Epigenetic mechanisms are uniquely capable of accounting for the multifactorial nature of the disease in that they are highly stable and are affected by environmental factors, including alcohol itself. Chromatin remodeling causes changes in gene expression in specific brain regions contributing to the endophenotypes of alcoholism such as tolerance and dependence. The epigenetic mechanisms that regulate changes in gene expression observed in addictive behaviors respond not only to alcohol exposure but also to comorbid psychopathology such as the presence of anxiety and stress. This review summarizes recent developments in epigenetic research that may play a role in alcoholism. We propose that pharmacologically manipulating epigenetic targets, as demonstrated in various preclinical models, hold great therapeutic potential in the treatment and prevention of alcoholism.
    International Review of Neurobiology 01/2014; 115:75-116. DOI:10.1016/B978-0-12-801311-3.00003-2 · 2.46 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The article deals with the prevailing paradigms of social policy. Drawing on the distinction between universalist (rights-based) and targeted (poverty-centred) social welfare policies, the authors examine the welfare regimes and recent policy innovations in Brazil, South Africa and India, namely conditional cash transfers, food transfer schemes and employment programmes. In order to reassess the relationship between targeting and universalism, they analyse the historical and contemporary dynamics of inclusion and exclusion. Their conclusion is that the two paradigms are not mutually exclusive. They propose to base the combat against poverty and inequality in emerging economies with persistent poverty and inequality on “targeted universalism”, thus avoiding the pitfalls of the dominant approaches.